Vizimpro 15 mg film-coated tablets, TAGRISSO 80 mg film-coated tablets
CAPLAND
Phase 2 small_molecule active
Quick answer
Vizimpro 15 mg film-coated tablets, TAGRISSO 80 mg film-coated tablets for Advanced or metastatic untreated EGFR mutation positive NSCLC is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Advanced or metastatic untreated EGFR mutation positive NSCLC
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active